HC Wainwright & Co. Reiterates Buy on OPKO Health, Maintains $3 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on OPKO Health (NASDAQ:OPK) and maintained a $3 price target on the stock.
February 28, 2024 | 6:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
OPKO Health receives a reiterated Buy rating and a maintained $3 price target from HC Wainwright & Co.
The reiteration of a Buy rating and maintenance of a $3 price target by a reputable analyst could positively influence investor sentiment towards OPKO Health, potentially leading to an increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100